Website

http://www.oncology-times.com/

Specialty

Oncology; Hematology; Nursing (Specialty)

Audience

Oncologists, hematology/oncologists, radiation oncologists, pediatric oncologists, oncology nurses, oncology specialists, surgical oncologists, urology oncologists

Content Focus

Oncology Times reports essential clinical news with independent analysis for today's oncologists, hematologists, and other cancer care professionals to optimize patient care and outcomes. The award-winning publication appears twice a month in print—mailed to approximately 41,000 readers— with daily updates online. Included are such popular regular departments and blogs as Dr. Joe Simone's OncOpinion, Dr. George Sledge’s Musings from a Cancer Doctor, and Dr. Wendy Harpham’s View from the Other Side of the Stethoscope, as well as How Do I Treat…?, Meeting Highlights from experts in various cancer subspecialties, Practice Matters, Point-Counterpoints, 3 Questions on…, and Conference listings. Also published regularly are Special Edition Meeting Reporters with news from major conferences; Clinical Spotlights; and FOCUS special edition supplements.

Oncology Times proudly brings you HemOnc Times, a hematology-focused supplement devoted entirely to bringing readers the “story behind the story.” HemOnc Times delves deeper into the latest news to bring a fresh perspective and offers advertisers a new and engaging space to market their products. If it’s happening in the field, we’ve got it covered. HemOnc Times is polybagged with Oncology Times to offer access to highly engaged Oncology Times readers and analyzes topics in leukemia, lymphoma, multiple myeloma, as well as CAR-T therapy, AML,CLL, NHL, and more. HemOnc Times will mail with the 2/20, 5/20, 8/20, and 11/20 issues of Oncology Times. HemOnc Times features a weekly eNewsletter sent to Oncology Times subscribers and exclusive online content— videos, podcasts, articles, and updates—updated weekly.

Editor-in-Chief

Pamela Tarapchak

Frequency

24 times a year

Advertising Guidelines

Subject to approval by Editor. New copy must be received by the Publisher two weeks before closing date.